[64Cu]Cu-AKY-1189 (imaging)

1 clinical trials involving this therapy/drug

This is not medical advice - consult your oncologist

Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.

RecruitingPhase IBreast cancerLung cancerCervical cancerColorectal cancerBladder cancerHead and neck cancerTriple negative (TNBC)Hormone receptor positive (HR+)Metastatic / advanced

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117ClinicalTrials.gov ↗

This is a first-in-human Phase 1b, 2-part, multicenter open-label clinical study to evaluate safety and efficacy of a Nectin-4 radiopharmaceutical (\[225Ac\]Ac-AKY-1189) in patients with locally advanced or metastatic solid tumors and to establish the maximum tolerated dose (MTD) or maximum administered dose (MAD) and the recommended Phase 2 dose.

Full details →

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.